Ascendis Pharma AS

A71

Company Profile

  • Business description

    Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

  • Contact

    Tuborg Boulevard 12
    HellerupDK-2900
    DNK

    T: +45 70222244

    E: [email protected]

    https://www.ascendispharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,017

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,688.0035.50-0.41%
CAC 407,589.330.33-0.00%
DAX 4023,356.716.160.03%
Dow JONES (US)42,206.8235.160.08%
FTSE 1008,781.636.980.08%
HKSE23,689.13158.650.67%
NASDAQ19,447.4198.86-0.51%
Nikkei 22538,354.0949.14-0.13%
NZX 50 Index12,532.6536.40-0.29%
S&P 5005,967.8413.03-0.22%
S&P/ASX 2008,474.9030.60-0.36%
SSE Composite Index3,381.5821.690.65%

Market Movers